Back
Y-mAbs Therapeutics Stock Price Chart
10 stocks to buy for the next leg of this rally
Get the full list here FREE
Buy
55
YMAB
Y-mAbs Therapeutics
Last Price:
$4.61
Seasonality Move:
7.09%
7 Day Trial
ALL ACCESS PASS
$
7
10 Best Stocks to Own in 2025
Get your copy now FREE!-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and YMAB is experiencing slight selling pressure.
Y-mAbs Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.4 | Buy |
| 20-day SMA: | 4.17 | Buy |
| 50-day SMA: | 4.42 | Buy |
| 200-day SMA: | 8.88 | Sell |
| 8-day EMA: | 4.44 | Buy |
| 20-day EMA: | 4.31 | Buy |
| 50-day EMA: | 4.58 | Buy |
| 200-day EMA: | 7.52 | Sell |
Y-mAbs Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 56.43 | Buy |
| Chaikin Money Flow: | -33440 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.93 - 4.43) | Buy |
| Bollinger Bands (100): | (4.19 - 6.21) | Sell |
Y-mAbs Therapeutics Technical Analysis
| May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Y-mAbs Therapeutics Stock
Is Y-mAbs Therapeutics Stock a Buy?
-
Y-mAbs Therapeutics share price is 4.60 while YMAB 8-day simple moving average is 4.40, which is a Buy signal.
-
The stock price of YMAB is 4.60 while Y-mAbs Therapeutics 20-day SMA is 4.17, which makes it a Buy.
-
Y-mAbs Therapeutics 50-day simple moving average is 4.42 while YMAB share price is 4.60, making it a Buy technically.
-
YMAB stock price is 4.60 and Y-mAbs Therapeutics 200-day simple moving average is 8.88, creating a Sell signal.
YMAB Technical Analysis vs Fundamental Analysis
Buy
55
Y-mAbs Therapeutics (YMAB)
is a Buy
Is Y-mAbs Therapeutics a Buy or a Sell?
-
Y-mAbs Therapeutics stock is rated a BuyThe current Y-mAbs Therapeutics [YMAB] share price is $4.60. The Score for YMAB is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
Y-mAbs Therapeutics Stock Info
Market Cap:
208.4M
Price in USD:
4.60
Share Volume:
253.2K
Y-mAbs Therapeutics 52-Week Range
52-Week High:
16.11
52-Week Low:
3.55
Buy
55
Y-mAbs Therapeutics (YMAB)
is a Buy
Y-mAbs Therapeutics Share Price Forecast
-
What is the Y-mAbs Therapeutics stock price today?The Y-mAbs Therapeutics stock price is 4.60 USD today.
-
Will YMAB stock go up or go down?Y-mAbs Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Y-mAbs Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Y-mAbs Therapeutics is not overvalued.
Is Y-mAbs Therapeutics Stock a Buy?
-
Y-mAbs Therapeutics share price is 4.60 while YMAB 8-day exponential moving average is 4.44, which is a Buy signal.
-
The stock price of YMAB is 4.60 while Y-mAbs Therapeutics 20-day EMA is 4.31, which makes it a Buy.
-
Y-mAbs Therapeutics 50-day exponential moving average is 4.58 while YMAB share price is 4.60, making it a Buy technically.
-
YMAB stock price is 4.60 and Y-mAbs Therapeutics 200-day simple moving average is 7.52, creating a Sell signal.
Fundamental Analysis of Y-mAbs Therapeutics
Is Y-mAbs Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.34 per share, and a decrease next year of $0.09 per share.
Technical Analysis of Y-mAbs Therapeutics
Should I short Y-mAbs Therapeutics stock?
-
YMAB Moving Average Covergence Divergence (MACD) indicator is 0.04, suggesting Y-mAbs Therapeutics is a Buy
-
Y-mAbs Therapeutics Relative Strength Index (RSI) is 56.43, which suggest Y-mAbs Therapeutics is overbought
-
The Bollinger Bands (25) for Y-mAbs Therapeutics is (3.93 - 4.43), which suggest Y-mAbs Therapeutics is a Sell
-
The Bollinger Bands (100) for Y-mAbs Therapeutics is (4.19 - 6.21), which suggest Y-mAbs Therapeutics is a Sell
* Y-mAbs Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.